interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Trazodone Hydrochloride

Generic competition · all medicines · read 12 November 2026

Is there a generic of Trazodone Hydrochloride, and who makes it?

Trazodone Hydrochloride appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 12 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 1.5 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Trazodone Hydrochloride3 dosage-form groups in the Orange Book
12generic makers listed
  1. Trazodone Hydrochloride appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 12 generic makers listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came 1.5 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Four or more generic makers listed

Every brand product here is listed as discontinued. 12 generic makers with 42 generic products listed as marketed; the first generic approval is dated 10 October 1986.

1985199019952000200520102015202020252030012brand 1985Apotex Inc, first approval 25 March 1987Teva Pharmaceuticals Usa Inc, first approval 11 December 1987Pliva Inc, first approval 9 March 1988Oxford Pharmaceuticals Llc, first approval 2 February 1989Sun Pharmaceutical Industries Inc, first approval 24 March 1993Torrent Pharmaceuticals Ltd, first approval 27 November 2013Accord Healthcare Inc, first approval 8 September 2017Zydus Pharmaceuticals Usa Inc, first approval 10 October 2017Aurobindo Pharma Ltd, first approval 5 February 2020Crossmedika Sa, first approval 20 May 2024Granules India Ltd, first approval 8 August 2024Graviti Pharmaceuticals Private Ltd, first approval 27 August 2024data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Apotex Inc25 March 19874
Teva Pharmaceuticals Usa Inc11 December 19872
Pliva Inc9 March 19881
Oxford Pharmaceuticals Llc2 February 19894
Sun Pharmaceutical Industries Inc24 March 19933
Torrent Pharmaceuticals Ltd27 November 20134
Accord Healthcare Inc8 September 20174
Zydus Pharmaceuticals Usa Inc10 October 20174
Aurobindo Pharma Ltd5 February 20204
Crossmedika Sa20 May 20244
Granules India Ltd8 August 20244
Graviti Pharmaceuticals Private Ltd27 August 20244

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Tablet, Extended Release, Oral

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed.

2010201520202025203001brand 2010data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Raldesy. No generic is listed as marketed.

20202025203001brand 2024data datePatent 8133893 listed to expire 13 March 2029
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 13 March 2029Patent 8133893 drug substance

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.